Art. -Nr.: HY-146683

KS106

Kundenbewertung

Based on 1 Customer Validation

KS106 is a potent ALDH inhibitor with IC₅₀s of 334, 2137, 360 nM for ALDH1A1, ALDH2, and ALDH3A1, respectively. KS106 shows antiproliferative and anticancer effects with low low toxic.KS106 significantly increases ROS activity, lipid peroxidation and toxic aldehyde accumulation. KS106 induces apoptosis and cell cycle arrest at the G2/M phase.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

Reinheit: 99.87%
CAS. Nr.: 2408477-50-7
Formel: C₁₈H₁₅BrF₃N₃O₂S
Molecular Weight:474.29

Speicherung:

4°C, sealed storage, away from moisture and light

* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)

KS106 Chemical Structure

CAS. Nr.: 2408477-50-7

Größe

Preis

Verfügbarkeit

Menge

Amount: USD 0.00

* Bitte wählen Sie Menge, bevor Sie Artikel hinzufügen.

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biologische Aktivität
- Beschreibung
- IC₅₀ & Target
- Cellular Effect
- In Vitro
Chemical Information
Lösungsmittel & Löslichkeit
- In Vitro
- In Vivo
Reinheit & Dokumentation
Verweise
Help & FAQs
Classifications
Bioz

Biologische Aktivität

Beschreibung

IC₅₀ & Target

ALDH2

2137 nM (IC₅₀)

ALDH1A1

334 nM (IC₅₀)

ALDH3A1

360 nM (IC₅₀)

Alle Aldehyde Dehydrogenase (ALDH) Isoform-spezifische Produkte anzeigen :

Cellular Effect

Cell Line	Type	Value	Description	References
HCT-116	IC₅₀	5.7 μM Compound: 3h; KS106	Antiproliferative activity against human HCT116 cells measured after 72 hrs by MTS assay Antiproliferative activity against human HCT116 cells measured after 72 hrs by MTS assay	[PMID: 31887569]
HT-29	IC₅₀	4.9 μM Compound: 3h; KS106	Antiproliferative activity against human HT-29 cells measured after 72 hrs by MTS assay Antiproliferative activity against human HT-29 cells measured after 72 hrs by MTS assay	[PMID: 31887569]
MM1.S	IC₅₀	2.2 μM Compound: 3h; KS106	Antiproliferative activity against human MM.1S cells measured after 72 hrs by MTS assay Antiproliferative activity against human MM.1S cells measured after 72 hrs by MTS assay	[PMID: 31887569]
NCI-H929	IC₅₀	1.5 μM Compound: 3h; KS106	Antiproliferative activity against human NCIH929 cells measured after 72 hrs by MTS assay Antiproliferative activity against human NCIH929 cells measured after 72 hrs by MTS assay	[PMID: 31887569]
RPMI-8226	IC₅₀	1.6 μM Compound: 3h; KS106	Antiproliferative activity against human RPMI8226 cells measured after 72 hrs by MTS assay Antiproliferative activity against human RPMI8226 cells measured after 72 hrs by MTS assay	[PMID: 31887569]
U-266	IC₅₀	2.6 μM Compound: 3h; KS106	Antiproliferative activity against human U266 cells measured after 72 hrs by MTS assay Antiproliferative activity against human U266 cells measured after 72 hrs by MTS assay	[PMID: 31887569]
UACC-903	IC₅₀	5.7 μM Compound: 3h; KS106	Antiproliferative activity against human UACC 903 cells measured after 72 hrs by MTS assay Antiproliferative activity against human UACC 903 cells measured after 72 hrs by MTS assay	[PMID: 31887569]

In Vitro

KS106 (compound 3h) (0-100 µM; 72 h) shows anti-proliferative activity with IC₅₀s of 5.7, 5.7, 5.7, 4.9, 1.5, 2.6, 1.6, 1.7, 2.2, 20.7 µM for UACC 903, 1205 Lu, HCT116, HT29, NCIH929, U266, RPMI8226, MM.1R, MM.1S, FF2441 cells, respectively^[1].
KS106 (5 µM, 24 h) induces apoptosis and cell cycle arrest at the G2/M phase^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Apoptosis Analysis^[1]

Cell Line:

HCT116, HT29 cells
Concentration:

5 µM
Incubation Time:

24 h
Result:

Induced cell apoptosis.

Cell Cycle Analysis^[1]

Cell Line:

HCT116 cells
Concentration:

5 µM
Incubation Time:

24 h
Result:

Induced cell cycle arrest at G2/M phase.

Chemical Information

CAS. Nr. 2408477-50-7
Appearance Solid
Molecular Weight 474.29
Formel C₁₈H₁₅BrF₃N₃O₂S
Color Light yellow to yellow
SMILES

N=C(SCC1=CC=C(C=C1)CN2C(C(C3=CC(C(F)(F)F)=CC=C32)=O)=O)N.Br
Versand

Room temperature in continental US; may vary elsewhere.
Speicherung

4°C, sealed storage, away from moisture and light

* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)

Lösungsmittel & Löslichkeit

In Vitro:

DMSO : 100 mg/mL (210.84 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

View the Complete Stock Solution Preparation Table

Preparing Stock Solutions

View the Complete Stock Solution Preparation Table

Concentration Solvent Mass

1 mg

5 mg

10 mg

Concentration

Solvent

Mass

1 mM

2.1084 mL

10.5421 mL

21.0841 mL

5 mM

0.4217 mL

2.1084 mL

4.2168 mL

10 mM

0.2108 mL

1.0542 mL

2.1084 mL

Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.

Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Molaritätsrechner

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Konzentration Konzentration

Volumen Volumen

Molecular Weight Molecular Weight

Verdünnungsrechner

Konzentration _{(Stammlösung)} × Volumen _{(Stammlösung)} = Konzentration _{(Ziellösung)} × Volumen _{(Ziellösung)}

Konzentration _{(Stammlösung)} Konzentration _{(Stammlösung)}

Volumen _{(Stammlösung)} Volumen _{(Stammlösung)}

Konzentration _{(Ziellösung)} Konzentration _{(Ziellösung)}

Volumen _{(Ziellösung)} Volumen _{(Ziellösung)}

In Vivo:

Select the appropriate dissolution method based on your experimental animal and administration route.

Stock Solution Working Solution

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

Protocol 1

Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline

Solubility: ≥ 2.5 mg/mL (5.27 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

Protocol 2

Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)

Solubility: ≥ 2.5 mg/mL (5.27 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.

In Vivo Dissolution Calculator

Please enter the basic information of animal experiments:

Dosage Dosage
mg/kg
Animal Weight (Per Animal) Animal Weight (Per Animal)
g
Dosing Volume (Per Animal) Dosing Volume (Per Animal)
μL
Number of Animals Number of Animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Please enter your animal formula composition:

%
DMSO +

Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
%
+
+
%
Tween-80 + +
%
Saline +

The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).

Working solution concentration: 0.22 mg/mL

Reinheit & Dokumentation

Select Batch:

Reinheit: 99.98%

Assay: 99.98%

ee.: 99.98%

Data Sheet (273 KB)
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
COA (2659 KB)
Elemental Analysis Report (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
Handling Instructions (2659 KB)

Verweise

[1]. Dinavahi SS, et al. Design, synthesis characterization and biological evaluation of novel multi-isoform ALDH inhibitors as potential anticancer agents. Eur J Med Chem. 2020 Feb 1;187:111962. [Content Brief]

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Complete Stock Solution Preparation Table

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg
DMSO	1 mM	2.1084 mL	10.5421 mL	21.0841 mL	52.7104 mL
	5 mM	0.4217 mL	2.1084 mL	4.2168 mL	10.5421 mL
	10 mM	0.2108 mL	1.0542 mL	2.1084 mL	5.2710 mL
	15 mM	0.1406 mL	0.7028 mL	1.4056 mL	3.5140 mL
	20 mM	0.1054 mL	0.5271 mL	1.0542 mL	2.6355 mL
	25 mM	0.0843 mL	0.4217 mL	0.8434 mL	2.1084 mL
	30 mM	0.0703 mL	0.3514 mL	0.7028 mL	1.7570 mL
	40 mM	0.0527 mL	0.2636 mL	0.5271 mL	1.3178 mL
	50 mM	0.0422 mL	0.2108 mL	0.4217 mL	1.0542 mL
	60 mM	0.0351 mL	0.1757 mL	0.3514 mL	0.8785 mL
	80 mM	0.0264 mL	0.1318 mL	0.2636 mL	0.6589 mL
	100 mM	0.0211 mL	0.1054 mL	0.2108 mL	0.5271 mL

Keywords

Produktname:
Art. -Nr.:
Menge:
MCE Japan Authorized Agent:

Produktname:
CAS. Nr.:
Species:
Reinheit:
Menge:

KS106

Apoptosis Compound Library

Metabolism/Protease Compound Library

Anti-Cancer Compound Library

Covalent Screening Library

Ferroptosis Compound Library

Glutamine Metabolism Compound Library

Anti-Cancer Metabolism Compound Library

Cancer Stem Cells Compound Library

Metabolic Enzyme Compound Library

Cell Death Library

Multi-Target Compound Library

Bioactive Compound Library Max

MCE Bioactive Compound Library

Covalent Screening Library Plus

Bioactive Compound Library

Non-Alcoholic Fatty Liver Disease (NAFLD) Compound Library

High-Throughput Bioactive Compound Library

Alle Aldehyde Dehydrogenase (ALDH) Isoform-spezifische Produkte anzeigen

Biologische Aktivität

Chemical Information

Lösungsmittel & Löslichkeit

Reinheit & Dokumentation

Verweise

Help & FAQs

Complete Stock Solution Preparation Table

KS106

Apoptosis Compound Library

Metabolism/Protease Compound Library

Anti-Cancer Compound Library

Covalent Screening Library

Ferroptosis Compound Library

Glutamine Metabolism Compound Library

Anti-Cancer Metabolism Compound Library

Cancer Stem Cells Compound Library

Metabolic Enzyme Compound Library

Cell Death Library

Multi-Target Compound Library

Bioactive Compound Library Max

MCE Bioactive Compound Library

Covalent Screening Library Plus

Bioactive Compound Library

Non-Alcoholic Fatty Liver Disease (NAFLD) Compound Library

High-Throughput Bioactive Compound Library

Alle Aldehyde Dehydrogenase (ALDH) Isoform-spezifische Produkte anzeigen

Biologische Aktivität

Chemical Information

Lösungsmittel & Löslichkeit

Reinheit & Dokumentation

Verweise

Help & FAQs

Complete Stock Solution Preparation Table

KS106 Related Classifications

HY-146683 Related Classifications